Research finds that chatbot interventions are effective in improving physical activity, diet, and sleep. The study highlights the efficacy of chatbots across different populations and age groups, emphasizing their potential for personalized healthcare delivery.
UK NICE recommends Accord’s Relugolix for prostate cancer
Relugolix offers a more convenient and flexible treatment option than injectable therapies. Credit: NICE. The UK National Institute for Health and Care Excellence (Nice) has
July 22, 2024